GLP-1 drugs are helpful for children who are living with severe obesity, research finds

Children who are living with severe obesity are more likely to experience a clinically relevant change in BMI when GLP-1 agonist drugs form part of their treatment, new research being presented at the European Congress on Obesity (ECO 2025) suggests.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup